These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7969326)

  • 1. Detection of a common mutation in factor V gene responsible for resistance to activate protein C causing predisposition to thrombosis.
    Ferreira-Gonzalez A; Fisher LM; Lehman CM; Langley MH; Lofland DH; Xia Q; Nguyen NX; Modesto D; Willoughby JB; Wilkinson DS; Garrett CT
    J Clin Lab Anal; 1997; 11(6):328-35. PubMed ID: 9406051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.
    Ehsani M; Imani A; Moravveji A
    Mol Biol Rep; 2018 Aug; 45(4):621-624. PubMed ID: 29855758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients.
    Akın DF; Sipahi K; Kayaalp T; Eğin Y; Taşdelen S; Kürekçi E; Ezer U; Akar N
    Leuk Res Treatment; 2012; 2012():250432. PubMed ID: 23198154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiac artery embolism due to thrombophilia - a case report.
    Trellopoulos G; Pikilidou MI; Tsiga E
    Int J Angiol; 2009; 18(2):96-8. PubMed ID: 22477502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden. luscaber@tin.it.
    Girolami A; Simioni P; Scarano L; Girolami B; Zerbinati P
    J Thromb Thrombolysis; 2000 Apr; 9(3):271-5. PubMed ID: 10728027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation.
    Toss H; Ernofsson M; Wallentin L; Seigbahn A
    J Thromb Thrombolysis; 1998; 5(1):3-7. PubMed ID: 10608043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of inherited and acquired thrombophilias.
    Spencer FA; Becker RC
    J Thromb Thrombolysis; 1999 Apr; 7(2):91-104. PubMed ID: 10364773
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.
    Pedersen OD; Gram J; Jespersen J
    Heart; 1997 Feb; 77(2):122-7. PubMed ID: 9068393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UK.
    Cavenagh JD; Colvin BT
    Postgrad Med J; 1996 Feb; 72(844):87-94. PubMed ID: 8871458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden: who should be tested?
    Solymoss S
    CMAJ; 1996 Aug; 155(3):296-8. PubMed ID: 8705909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation.
    Emmerich J; Alhenc-Gelas M; Aillaud MF; Juhan-Vague I; Jude B; Garcin JM; Dreyfus M; de Moerloose P; Le Querrec A; Priollet P; Berruyer M; Vallantin X; Wolf M; Aiach M; Fiessinger JN
    Thromb Haemost; 1997 Apr; 77(4):620-3. PubMed ID: 9134631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.